TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here.
pirfenidone |
pirfenidoneATS: Pirfenidone Slows IPF Lung DeclinesMedPage Today Allergy & Immunology Tue, 05/20/2008 - 14:05
TORONTO -- An investigational anti-fibrotic agent is showing promise in the treatment of idiopathic pulmonary fibrosis (IPF), a researcher said here. |
